Graeme Clark Collection
Permanent URI for this collection
Search Results
1 - 10 of 31
-
ItemContributing factors to improved speech perception in children using the nucleus 22-channel cochlear prosthesis( 1997)It has been established that use of multiple-channel intracochlear implants can significantly improve speech perception for postlinguistically deafened adults. In the development of the Nucleus 22-channel cochlear implant, there have been significant developments in speech processing strategies, providing additional benefits to speech perception for users. This has recently culminated in the release of the Speak speech processing strategy, developed from research at the University of Melbourne. The Speak strategy employs 20 programmable bandpass filters which are scanned at an adaptive rate, with the largest outputs of these filters presented to up to ten stimulation channels along the electrode array. Comparative studies of the Speak processing strategy (in the Nucleus Spectra-22 speech processor), with the previously-used Multipeak (Multipeak) speech processing strategy (in the Minisystem-22 speech processor), with profoundly deaf adult cochlear implant users have shown that the Speak processing strategy provides a significant benefit to adult users both in quiet situations and particularly in the presence of background noise. Since the first implantation of the Nucleus device in a profoundly hearing-impaired child in Melbourne in 1985, there has been a rapid growth in the number of children using this device. Studies of cochlear implant benefits for children using the Nucleus 22-channel cochlear implant have also shown that children can obtain significant benefits to speech perception, speech production and language, including open-set understanding of words and sentences using the cochlear implant alone. In evaluating contributing factors to speech perception benefits available for children, four specific factors are important to investigate: (1) earlier implantation -resulting from earlier detection of deafness; (2) improved hardware and surgical techniques -allowing implantation in infants; (3) improved speech processing, and (4) improved habilitation techniques. Results reported previously have been recorded primarily for children using the Multipeak strategy implemented in the MSP speech processor. While it is important to evaluate the factors which might contribute to improvements in speech perception benefits, an important question is the effect of improved speech processing strategy, since this will determine what is perceived through the device. Given that adult patients changing to the Spectra speech processor had also shown improved perception in noisy situations, and the fact that children are in general in noisy environments in the classroom setting for a large proportion of their day, it was of obvious interest to evaluate the potential for benefit in poor signal-to-noise ratios from use of the Speak processing strategy and from specific training in the ability to perceive in background noise. The study was aimed at evaluating whether children who were experienced in use of the Multipeak speech processing strategy would be able to changeover to the new Speak processing strategy, which provides a subjectively different output. Secondly, the study aimed to evaluate the benefits which might accrue to children from use of controlled habilitation in background noise.
-
ItemThe Melbourne Cochlear Implant Clinic program(Singular Publishing, 1997)The Melbourne Cochlear Implant Clinic program involves a multidisciplinary clinical team, collaborating with those engaged in more fundamental research, and with the biomedical company Cochlear Limited. This chapter reflects the contributions of many professionals to managing children with cochlear implants.
-
ItemIntroduction(Singular Publishing, 1997)From the time single-channel cochlear implants were first implanted in children in the early 1980s in Los Angeles (Laxford et al 1987) closely followed in 1985 by the multiple-channel cochlear implant in Melbourne (Clark et al 1987a, 1987b) there has been a considerable expansion in the work to apply the multiple-channel cochlear implant to infants and young children.
-
ItemEthical issues(Singular Publishing, 1997)The ethics of cochlear implantation in infants and children is an important issue which has received a lot of attention, in particular from the signing deaf community and their advocates. Many of the issues raised by the signing deaf community are in regard to human experimentation and are therefore ethical in nature. Others are concerned with whether it is natural to have a hearing loss, and this goes beyond the realm of ethics. This chapter examines cochlear implantation in children in light of generally accepted ethical principles.
-
ItemMultichannel auditory brainstem implants: an Australian case study [Abstract]( 1996)The multichannel Auditory Brainstem Implant (ABI) is an implantable device designed to restore a level of auditory perception in patients with bilateral acoustic neuromas, where the removal of the tumours is expected to result in a total loss of hearing. As with the cochlear implant, the ABI utilises an externally worn speech processor and headset, together with a surgically-placed receiver-stimulator and electrode array. The electrode array, developed through the collaboration of the House Ear Institute in the United States and Cochlear Corporation, consists of eight electrodes on a carrier, which is placed on the surface of the brainstem in the area of the cochlear nucleus.
-
ItemA training program for use with multichannel speech perception/production tactile devices [Abstract]( 1996)Over the past ten years, there have been remarkable improvements in both conventional hearing aid technology and in the use of multichannel cochlear prostheses. These developments have resulted in improved speech perception for severely and profoundly hearing impaired adults and children. However, a small number of adults and children remain unable to benefit from either of these prosthetic approaches. This may occur as a result of medical/surgical issues, which render implantation unfeasible, or from a decision by the patient or parents that the device is inappropriate for the individual person. In these cases, use of a supplemental speech perception device employing the intact tactile modality has been advocated. A number of single and multichannel devices have been developed, both commercially and in the laboratory. One of these, the Tickle Talker, a multichannel electrotactile speech processor, has been developed and thoroughly evaluated with both adults and children at the University of Melbourne. Benefits to speech perception have been noted on both closed-set phonemic discrimination tests, and on open-set word and sentence scores, where the device was used to supplement lipreading and/or aided residual hearing. Benefits to articulation have also been noted. Recently, improved speech processing and the design of a new electrode handset have been implemented. While these factors are important to device acceptance, the critical factor in improving speech perception and production appears to be the training program which is employed with the device. The program must be based on the information available through the device, but organised to emphasize the integration of tactually-encoded speech information into open-set understanding of words and sentences if communication is to be improved. The important elements of the program will be discussed. At present, no tactile device is able to provide sufficient information for open-set speech understanding using only the tactile input. While this may be an ultimate goal, significant periods of training may be required to achieve this outcome.
-
ItemA clinical report on speech production of cochlear implant users( 1995)Objective: The aim was to assess articulation and speech intelligibility over time in a group of cochlear implant users implanted at 8 yr or over. The hypothesis was that the postoperative speech production performance would be greater than the preoperative performance. Design: A test of intelligibility using sentences and an articulation test measuring non-imitative elicited speech were administered to 11 and 10 subjects, respectively, who were implanted with the 22-electrode cochlear implant. Nine subjects received both tests. Age at implantation ranged from 8 yr to 20 yr and implant use ranged from 1 yr to 4 yr 5 mo. Results: For both the intelligibility and articulation tests roughly half of the subjects showed significant improvements over time and group mean postoperative performance significantly exceeded preoperative performance. Improvements occurred for front, middle, and back consonants; for stops, fricatives, and glides and for voiceless and voiced consonants. Conclusions: Despite being deprived of acoustic speech information for many childhood years, roughly half of the patients assessed showed significant gains in speech intelligibility and articulation postimplantation. The lack of a control group of non-implanted patients means that we cannot separate out the influence of the implant on speech production from other influences such as training and tactile-kinaesthetic feedback.
-
ItemSpeech perception for children with different levels of residual hearing using the cochlear 22-channel cochlear prosthesis [Abstract[( 1996)Over the past 10 years, since the implantation of the first children with the Nucleus 22-channel cochlear prosthesis in Melbourne, the number of profoundly deaf children using this implant system has rapidly expanded. Longer-term experience with implanted children has led to improvements in paediatric assessment and management. Speech processing strategies have also been improved, resulting in a series of increases in speech perception benefits. Results of comparative studies of Speak and Multipeak speech processing strategies have shown that open-set word and sentence scores for a group of thirteen children evaluated over a two year period showed an advantage with the Speak speech processing strategy. The increases were noted particularly in speech perception in poor signal-to-noise conditions. Analysis has shown that consonant perception was significantly increased, due to an improved place perception. Given current speech perception scores for implanted children, it has been suggested that severely-to-profoundly deaf children currently using hearing aids could in fact benefit more from a cochlear implant. Preliminary investigation of results for children in the Melbourne and Sydney cochlear implant programs has shown that children with higher levels of preoperative residual hearing as a group do score significantly on open-set word and sentence perception tests using the implant alone. In children with lower levels of residual hearing, results were variable across the group.
-
ItemIntroduction: International Cochlear Implant, Speech and Hearing Symposium - Melbourne 1994( 1995)The International Cochlear Implant Speech and Hearing Symposium - Melbourne 1994 covered a wide range of presentations in a number of disciplines. The scientific program included 287 oral presentations and 40 posters, presented to a total of 456 delegates from 38 countries. This was a considerable expansion in the number and range of presentations from the first international conference held in Melbourne in 1985 (Ann Otol Rhinal Laryngal 1987;96[suppl 128]). This growth highlights the importance of the discipline and the advances being made in this area.
-
ItemSpeech perception in children using the advanced Speak speech-processing strategy( 1995)The Speak speech-processing strategy, developed by the University of Melbourne and commercialized by Cochlear Pty Limited for use in the new Spectra 22 speech processor, has been shown to provide improved speech perception for adults in both quiet and noisy situations. The present study evaluated the ability of children experienced in the use of the Multipeak (Mpeak) speech-processing strategy (implemented in the Nucleus Minisystem-22 cochlear implant) to adapt to and benefit from the advanced Speak speech-processing strategy (implemented in the Nucleus Spectra 22 speech processor). Twelve children were assessed using Mpeak and Speak over a period of 8 months. All of the children had over 1 year's previous experience with Mpeak, and all were able to score significantly on open-set word and sentence tests using the cochlear implant alone. Children were assessed with both live-voice and recorded speech materials, including Consonant-Nucleus-Consonant monosyllabic words and Speech Intelligibility Test sentences. Assessments were made in both quiet and in noise. Assessments were made at 3-week intervals to investigate the ability of the children to adapt to the new speech-processing strategy. For most of the children, a significant advantage was evident when using the Speak strategy as compared with Mpeak. For 4 of the children, there was no decrement in speech perception scores immediately following fitting with Speak. Eight of the children showed a small (10% to 20%) decrement in speech perception scores for between 3 and 6 weeks following the changeover to Speak. After 24 weeks' experience with Speak, 11 of the children had shown a steady increase in speech perception scores, with final Speak scores higher than for Mpeak. Only 1 child showed a significant decrement in speech perception with Speak, which did not recover to original Mpeak levels.